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INTRODUCTION
Domestic violence and abuse (DVA) 
encompass ‘any incident or pattern 
of incidents of controlling, coercive, 
threatening behaviour, violence or abuse 
between those aged 16 or over who are, 
or have been, intimate partners or family 
members’.1 Although experienced across 
the sexes, health consequences of DVA 
are reported as being worse among 
women, mainly impacting on their mental 
and reproductive health.2 Two systematic 
reviews have found an association between 
exposure to DVA and reduction in use of 
regular contraception.3,4 The authors’ recent 
systematic review found some evidence for 
a positive association between exposure to 
DVA and use of emergency contraception 
(EC).5 However, none of these reviews 
included UK studies.
The negative impact of DVA on health 
results in higher presentation of women 
exposed to DVA among healthcare service 
users compared with general populations. 
Between 7 and 17% of female patients 
in general practice reported experiencing 
DVA in the previous year.6–8 National and 
international health organisations identify 
primary care providers as an important 
point of contact for victims of DVA and 
survivors.9–12 Patients perceive healthcare 
professionals as being well placed 
to enquire about DVA and respond to 
disclosure.13 World Health Organization 
(WHO)12 and National Institute for Health 
and Care Excellence (NICE)11 guidelines 
recommend a case-finding or clinical 
enquiry approach to DVA identification, 
prompted by clinical conditions associated 
with DVA. Recommended initial response 
to disclosure should follow the WHO LIVES 
principles: Listen, Inquire about needs and 
concerns, Validate, Enhance safety, provide 
Support.14 A number of DVA resources for 
healthcare professionals are available in 
the UK,15–18 including the Identification and 
Referral to Improve Safety (IRIS) model — a 
training, support, and referral programme 
for general practice19–22 and sexual health 
services,23,24 currently implemented across 
30 administrative areas. None of the existing 
DVA training sources includes presentation 
for EC as a condition associated with DVA 
that should trigger clinical enquiry. As the 
association between DVA and use of EC 
can be influenced by the country context, 
such as access to EC,25,26 it is important to 
obtain the UK evidence to inform national 
clinical guidance and training resources on 
DVA. New evidence will inform clinicians’ 
decision making on DVA clinical enquiry, 
and potentially lead to more women with 
experience of DVA accessing evidence-
based interventions.
Research
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Background
Evidence of an association between exposure 
to domestic violence and abuse (DVA) and use 
of emergency contraception (EC) is lacking in 
the UK. 
Aim
To quantify the association between exposure 
to DVA and consultations for EC in general 
practice. 
Design and setting
Nested case-control study in UK general 
practice.
Method
Using the Clinical Practice Research Datalink, 
the authors identified all women all women 
aged 15–49 years registered with a GP between 
1 January 2011 and 31 December 2016. 
Cases with consultations for EC (n = 43 570) 
were each matched on age and GP against 
four controls with no consultations for EC 
(n = 174 280). The authors calculated odds 
ratios (ORs) and 95% confidence intervals 
(CIs) for the association between exposure to 
DVA in the previous year and consultations 
for EC. Covariates included age, ethnicity, 
socioeconomic status, pregnancy, children, 
alcohol misuse, and depression. 
Results
Women exposed to DVA were 2.06 times 
more likely to have a consultation for EC than 
unexposed women (95% CI = 1.64 to 2.61). 
Women aged 25–39 years with exposure to DVA 
were 2.8 times more likely to have a consultation 
for EC, compared with unexposed women 
(95% CI = 2.08 to 3.75). The authors found some 
evidence of an independent effect of exposure 
to DVA on the number of consultations for EC 
(OR 1.48, 95% CI = 0.99 to 2.21). 
Conclusion
A request for EC in general practice can 
indicate possible exposure to DVA. Primary 
care consultation for EC is a relevant context 
for identifying and responding to DVA as 
recommended by the World Health Organization 
and National Institute for Health and Care 
Excellence guidelines. DVA training for providers 
of EC should include this new evidence. 
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This study aimed to fill a gap in the 
UK-based evidence by quantifying the 
association between exposure to DVA 
and general practice consultation for EC. 
The primary objective was to estimate 
the association between exposure to DVA 
and consultations for EC. The secondary 
objective was to estimate whether there is 
an association between exposure to DVA 
and having multiple consultations for EC. 
The authors hypothesised that exposure to 
DVA is associated with an increase in EC 
consultations. 
METHOD
Study design
The authors conducted a nested case-
control study in the Clinical Practice 
Research Datalink (CPRD), which contains 
anonymised electronic primary care 
records for approximately 17 million 
patients registered at 718 participating 
general practices in the UK.27 Patients 
registered during any time period and 
meeting quality criteria monitored by the 
CPRD (about 15 million) are considered 
broadly representative of the UK population 
with regards to age, sex, and ethnicity. The 
time from the date when practice data were 
considered to meet CPRD standards for 
quality and completeness is defined as the 
period of up-to-standard (UTS) registration. 
CPRD data are recorded by general practice 
clinicians using version 2 Read codes, a 
hierarchical clinical classification system 
containing >96 000 codes.28 Prescriptions 
are automatically recorded with a product 
name and British National Formulary code.
The authors used CPRD data on patient 
demographics, consultations (medical 
codes), and prescriptions (product codes) 
recorded by clinicians as part of their usual 
medical practice. For each variable, one 
researcher ran searches and compiled a 
draft list of Read and drug codes,29 which 
was revised by two academic GPs and cross-
referenced with comparable code lists from 
the online clinical codes repository30 and 
the authors’ previous studies,19 leading to 
the final version of codes for data extraction 
(further details are available from the 
authors on request).
Participants
The authors identified female patients 
aged 15–49 years (the WHO definition 
of reproductive age)31 with any period of 
registration at a general practice between 
1 January 2011 and 31 December 2016. 
From this cohort, the authors identified 
all women with at least one record of EC 
consultation within the study period (cases). 
The date of the first EC consultation was 
defined as the case’s index date (or index 
consultation).
Each case was matched on age (year of 
birth ± 2 years) and general practice, with 
up to four controls who had no record of 
EC consultation within the study period 
and were randomly selected from the study 
population. Controls inherited the index 
date of their matched case. All patients 
were required to have at least 1 complete 
year of UTS medical history before their 
index date.
Potential controls were excluded if they 
had any indication that they would not have 
been eligible for, or needed, EC. The full 
list of inclusion and exclusion criteria, with 
justification, is available from the authors 
on request.
Variables
Exposure and outcomes. Primary outcome 
(an index consultation for EC) was the first 
occasion on which any EC Read or drug code 
from the authors’ list was entered in the 
patient medical record. Secondary outcome 
(multiple consultation for EC) was defined 
as having more than one consultation for 
EC, occurring >1 week apart and within 
12 months after the index consultation (to 
increase the likelihood that records relate to 
separate events occurring within a relatively 
short time period). 
Exposure to DVA was defined as the 
first retrospective record of any CPRD 
code for DVA within 12 months before the 
index consultation for EC, to meet the UK 
Home Office definition of DVA and allow an 
adequate window for exposure to affect the 
outcome (further details are available from 
the authors on request.
How this fits in
Professional awareness of clinical 
associations of domestic violence and 
abuse (DVA) is a first step towards the 
evidence-based healthcare response 
recommended by the World Health 
Organization and National Institute for 
Health and Care Excellence. This study’s 
findings fill the gap in evidence from 
UK primary care on the association 
between exposure to DVA and increased 
use of emergency contraception (EC). 
This study found that a request for EC 
in general practice can indicate possible 
exposure to DVA. A consultation for EC is 
an appropriate context for asking about 
DVA, responding supportively, and offering 
referral to specialist DVA services. 
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Covariates. The authors extracted CPRD 
and linkage data on known factors that 
affect women’s use of contraception.4 CPRD 
covariates included age (year of birth) and 
history of alcohol abuse (Read codes for any 
records of alcoholism, alcohol dependency, 
or alcohol induced disease since the age 
of 15 years), or depression (Read and drug 
codes for any records of depression or 
depressive episode within 2 years before the 
index date)30 (further details are available 
from the authors on request). 
Other covariates were extracted from 
datasets linked to CPRD. Information about 
patient ethnicity (white, black, Asian, mixed, 
other) was obtained via linkage to the 
Hospital Episode Statistics (HES) dataset. 
Socioeconomic status (quintiles of Indices 
of Multiple Deprivation [IMD]) was identified 
via linkage to the 2015 English IMD32 (2011 
lower layer super output area [LSOA] 
boundaries). Information about number of 
pregnancies was obtained from the CPRD 
pregnancy register, which contains details 
about all pregnancies identified in the CPRD 
using an algorithm developed to identify 
and maximise the use of records relating 
to the timing and duration of pregnancy, 
the type of pregnancy outcome (live birth, 
stillbirth, or pregnancy loss), and additional 
features pertaining to the pregnancy. The 
authors identified the number of children 
for each woman using the CPRD mother–
baby link, which contains data on mother–
baby pairings, linked using an algorithm 
that matches live births to maternal records 
in the CPRD. No restrictions relating to use 
of data from UTS time only within a practice 
are imposed, and therefore may include 
children born before the practice became 
UTS and those who initially registered 
at a different practice after birth, but 
Total patients in CPRD GOLD Database, July 2017 snapshot:
17 148 866 
Acceptable patients in CPRD GOLD Database July 2017:
14 942 430
(87% of total)
Cases
Acceptable patients with at least one
medical code for EC:
226 975
Acceptable patients with at least one
product code for EC:
230 936
Female:
226 863
Female:
230 827
With an event date between
1 January 2011 and 31 December 2016:
29 304
With an event date between
1 January 2011 and 31 December 2016:
50 148
Aged 15–49 inclusive:
28 830
Aged 15–49 inclusive:
49 297
With at least 1 year of previous
UTS registration:
24 363
With at least 1 year of previous
UTS registration: 
41 813
Eligible cases with a complete set of four
matched controls (duplicate cases removed):
43 570
Eligible controls matched to an included case:
174 280
Never had a medical or
product code for EC:
1 717 175
With year of birth between
1960 and 2003:
1 894 707
With any UTS registration between
1 January 2011 and 31 December 2016: 
3 647 181
Female:
7 746 319
Controls
Figure 1. Flow diagram reporting numbers of patients 
at each stage of the study. 
CPRD = Clinical Practice Research Datalink. 
EC = emergency contraception. UTS = up to standard. 
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subsequently joined the current practice.
Statistical analysis
Statistical analyses were performed 
using STATA version 15. The authors used 
univariable and multivariable conditional 
logistic regression models to estimate odds 
ratios (ORs) and 95% confidence intervals 
(CIs) for the association between record 
for DVA exposure and consultations for EC. 
The choice of analysis allowed the authors 
to take into account matched sets of cases 
and controls, among whom unmeasured 
confounders are assumed equal.
Multiple imputation for missing ethnicity 
or socioeconomic status was not performed, 
as the necessary data to inform the 
imputation were not available. The authors 
conducted an analysis of all subjects, 
excluding ethnicity and socioeconomic 
status from the model, and an analysis of 
complete cases adjusting for all covariates.
Secondary analysis used univariable and 
multivariable logistic regression to model 
the association between exposure to DVA 
and multiple consultations for EC among 
cases. 
RESULTS
The authors identified 43 570 eligible cases 
and 174 280 matched controls (Figure 1).
Cases and controls were similar in terms 
of age, ethnicity, and socioeconomic status 
(Table 1). Cases tended to have had more 
pregnancies and to have more children, 
and were more likely to have a history of 
depressive episodes. 
In the year before the index date, 0.35% 
of cases and 0.10% of controls had one or 
more record of DVA (Table 1). Compared 
with women with no record of DVA, women 
who had experienced DVA within the year 
before their index date were more than 
three times likely to have had one or more 
consultations for EC (OR 3.59, 95% CI = 2.88 
to 4.47) (Table 2).
Table 1. Demographic and patient characteristics of women who had 
a consultation for emergency contraception (cases), and women who 
did not have a consultation for emergency contraception (controls)
Variable  Cases, n (%) Controls, n (%)
Previous 12 months’ experience of  No  43 418 (99.65) 174 108 (99.90) 
domestic violence and abusea Yes  152 (0.35) 172 (0.10)
Mean age, years (standard deviation)  28.46 (8.29) 28.46 (8.41)
Age categories, years  15–24 15 844 (36.36) 63 510 (36.44) 
 25–39 22 545 (51.74) 89 410 (51.30) 
 40–49 5181 (11.89) 21 360 (12.26)
Ethnicity  White  17 986 (41.28) 56 450 (32.39) 
 Black 1001 (2.30) 2033 (1.17) 
 Asian 1065 (2.44) 3848 (2.21) 
 Mixed 389 (0.89) 800 (0.46) 
 Other 354 (0.81) 1370 (0.79) 
 Missing 22 775 (52.27) 109 779 (62.99)
Socioeconomic status  Least deprived: 1 4419 (10.14) 19 991 (11.47) 
(quintiles of level 2 4665 (10.71) 19 795 (11.36) 
of deprivation) 3 5140 (11.80) 20 252 (11.62) 
 4 5437 (12.48) 19 813 (11.37) 
 Most deprived: 5 5615 (12.89) 18 959 (10.88) 
 missing 18 294 (41.99) 75 470 (43.30)
Pregnancies, n 0 15 617 (35.84) 105 190 (60.36) 
 1 7209 (16.55) 24 178 (13.87) 
 ≥2 20 744 (47.61) 44 912 (25.77)
Children, n 0 25 426 (58.36) 133 040 (76.34) 
 1 10 623 (24.38) 25 472 (14.62) 
 ≥2 7521 (17.26) 15 768 (9.05)
History of alcohol misuse No  43 180 (99.10) 173 621 (99.62) 
since age 15a Yes 390 (0.90) 659 (0.38)
History of depression/depressive No  39 174 (89.91) 166 101 (95.31) 
episode within 2 yearsa Yes 4396 (10.09) 8179 (4.69)
aBefore the index date.
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Table 2. Association of domestic violence and abuse and other covariates with having a consultation for 
emergency contraception, univariable analysis
 All subjects Cases with complete data 
 (n = 217 850) (n = 22 135)
Variable  OR (95% CI) P-value OR (95% CI) P-value
Previous 12 months’ experience No 1.00  1.00  
of domestic violence and abusea Yes 3.59 (2.88 to 4.47) <0.000 3.37 (1.95 to 5.81) <0.000
Age categories, years 15–24 0.98 (0.92 to 1.04) 0.415 0.93 (0.75 to 1.16) 0.527 
 25–39 1.00  1.00  
 40–49 0.78 (0.72 to 0.85) <0.000 0.84 (0.69 to 1.04) 0.109
Ethnicity White  1.00  1.00  
 Black 1.60 (1.46 to 1.73) <0.000 1.42 (1.17 to 1.71) <0.000 
 Asian 0.87 (0.81 to 0.94) <0.000 0.87 (0.74 to 1.03) 0.099 
 Mixed 1.51 (1.33 to 1.71) <0.000 1.42 (1.07 to 1.90) 0.017 
 Other 0.81 (0.71 to 0.91) <0.000 0.61 (0.45 to 0.82) 0.001 
 Missing 0.37 (0.36 to 0.38) <0.000  
Socioeconomic status Least deprived: 1 1.00  1.00  
(quintiles of level of deprivation) 2 1.14 (1.09 to 1.20) <0.000 1.07 (0.94 to 1.21) 0.314 
 3 1.30 (1.23 to 1.36) <0.000 1.29 (1.14 to 1.47) <0.000 
 4 1.49 (1.41 to 1.57) <0.000 1.36 (1.20 to 1.55) <0.000 
 Most deprived: 5 1.74 (1.64 to 1.84) <0.000 1.66 (1.45 to 1.91) <0.000 
 Unknown 0.36 (0.32 to 0.41) <0.000  
Pregnancies, n 0 1.00  1.00  
 1 2.93 (2.83 to 3.04) <0.000 2.23 (1.98 to 2.52) <0.000 
 ≥2 5.56 (5.39 to 5.74) <0.000 4.39 (3.95 to 4.88) <0.000
Children, n 0 1.00  1.00  
 1 2.63 (2.55 to 2.71) <0.000 1.82 (1.68 to 1.97) <0.000 
 ≥2 3.27 (3.15 to 3.38) <0.000 2.18 (1.99 to 2.39) <0.000
History of alcohol misuse No  1.00  1.00  
since age 15a Yes 2.40 (2.11 to 2.72) <0.000 2.58 (1.83 to 3.64) <0.000
History of depression/depressive episode No  1.00  1.00  
within 2 yearsa Yes 2.32 (2.24 to 2.42) <0.000 1.98 (1.77 to 2.22) <0.000 
aBefore index date. 
Table 3. Association of domestic violence and abuse with having a consultation for emergency 
contraception, multivariable conditional logistic regressions models 
 All subjects Cases with complete data 
 (n = 217 850) (n = 22 135)
Model  Adjusted OR (95% CI) P-value Adjusted OR (95% CI) P-value
Previous 12 months DVAa  3.59 (2.88 to 4.47) <0.000 3.37 (1.95 to 5.81) <0.000
Previous 12 months DVAa and age categories  3.59 (2.88 to 4.47) <0.000 3.38 (1.96 to 5.84) <0.000
Previous 12 months DVAa and ethnicity    3.43 (1.99 to 5.94) <0.000
Previous 12 months DVAa and socioeconomic status    3.29 (1.90 to 5.70) <0.000
Previous 12 months DVAa and number of pregnancies  2.22 (1.76 to 2.80) <0.000 2.76 (1.57 to 4.85) <0.000
Previous 12 months DVAa and number of children  2.85 (2.27 to 3.58) <0.000 3.23 (1.85 to 5.61) <0.000
Previous 12 months DVAa and record of alcohol abuseb  3.54 (2.84 to 4.41) <0.000 3.20 (1.84 to 5.54) <0.000
Previous 12 months DVAa and record of depression/depressive episodec  3.28 (2.63 to 4.10) <0.000 3.12 (1.80 to 5.42) <0.000
Full model  2.06 (1.64 to 2.61) <0.000 2.53 (1.43 to 4.47) 0.001
Full model and previous 12 months DVAa 15–24 years 1.25 (0.82 to 1.93) 0.290 
multiplied by age interaction 25–39 years 2.78 (2.08 to 3.75) <0.000 
 40–49 years 1.23 (0.51 to 3.02) 0.643
aBefore index date. bSince age 15, before index date. cWithin 2 years before index date. DVA = domestic violence and abuse. OR = odds ratio.
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Table 4. Demographic and patient characteristics of cases who had multiple consultations for emergency 
contraception and women who had a single consultation for emergency contraception
Variable  Cases with a single consultation, n (%) Cases with multiple consultations, n (%)
Previous 12 months domestic  No  37 869 (99.68) 5549 (99.46) 
violence and abusea Yes 122 (0.32) 30 (0.54)
Age categories, years 15–24 13 693 (36.04) 2151 (38.56) 
 25–39 19 616 (51.63) 2929 (52.50) 
 40–49 4682 (12.32) 499 (8.94)
Pregnancies, n 0 13 927 (36.66) 1690 (30.29) 
 1 6204 (16.33) 1005 (18.01) 
 ≥2 17 860 (47.01) 2884 (51.69)
Children, n 0 22 266 (58.61) 3160 (56.64) 
 1 9140 (24.06) 1483 (26.58) 
 ≥2 6585 (17.33) 936 (16.78)
History of alcohol misuse No  37 822 (99.56) 5550 (99.48) 
since age 15a Yes 169 (0.44) 29 (0.52)
History of depression/depressive episode No 34 261 (90.18) 4913 (88.06) 
within 2 yearsa Yes 3730 (9.82) 666 (11.94) 
aBefore the index date.
When included individually, potential 
confounding factors changed odds ratios 
for exposure to DVA by percentages ranging 
from 0.8% to 38.2%, with number of 
pregnancies producing the largest change. 
After adjusting for all covariates, women 
who had been exposed to DVA were two 
times more likely to have a consultation for 
EC than women with no experience of DVA 
(OR 2.06, 95% CI = 1.64 to 2.61) (Table 3).
There was a positive interaction between 
exposure to DVA and age, with the odds of EC 
consultation being 2.8 times greater among 
women aged 25–39 years with exposure 
to DVA, compared with those without such 
exposure (OR 2.78, 95% CI = 2.08 to 3.75) 
(Table 3).
When restricted to women with complete 
data for all covariates, the overall pattern 
of results was similar to the main analysis, 
that is, women who had been exposed to 
DVA were more than twice as likely to have 
a consultation for EC than women with no 
experience of DVA (Tables 2 and 3). 
In the 12 months following their 
index date, 12.8% of cases had multiple 
consultations for EC. Demographic and 
patient characteristics were similar between 
cases who had a single consultation and 
cases who had multiple consultations for 
EC (Table 4).
In the 12 months before their index date, 
0.32% of cases with a single consultation 
for EC had one or more record of DVA, 
compared with 0.54% of cases with multiple 
consultations for EC (Table 4). Compared 
with women with no record of DVA, women 
who had experienced DVA within the 
12 months before their index date were 
1.7 times more likely to have had multiple 
consultations for EC (OR 1.68, 95% CI = 1.12 
to 2.50) (Table 5).
The addition of potential confounding 
factors to the model individually produced 
little change in odds ratios for exposure 
to DVA. When adjusted for all covariates, 
there was some evidence of an independent 
effect of exposure to DVA on the number of 
consultations for EC (OR 1.48, 95% CI = 0.99 
to 2.21) (Table 6). 
The positive interaction between exposure 
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Table 5. Association of domestic violence and abuse and other 
covariates with having multiple consultations for emergency 
contraception, univariable analysis
Variable  OR (95% CI) P-value
Previous 12 months domestic No 1.00   
violence and abusea  Yes 1.68 (1.12 to 2.50) 0.011
Age categories, years  15–24 1.05 (0.99 to 1.12) 0.096 
 25–39 1.00   
  40–49 0.71 (0.65 to 0.79) 0.000
Pregnancies, n 0 1.00   
 1 1.33 (1.23 to 1.45) 0.000 
 ≥2 1.33 (1.25 to 1.42) 0.000
Children, n 0 1.00   
 1 1.14 (1.07 to 1.22) 0.000 
 ≥2 1.00 (0.93 to 1.08) 0.969
History of alcohol abuse No  1.00   
within 2 yearsa Yes 1.17 (0.79 to 1.74) 0.437
History of depression/depressive episode No  1.00   
within 2 yearsa Yes 1.25 (1.14 to 1.36) 0.000 
aBefore the index date. OR = odds ratio. 
to DVA and age remained, with the odds 
of having multiple consultations for EC 
being 1.7 times greater among women 
aged 25–39 years with exposure to DVA, 
compared to those without such exposure 
(OR 1.67, 95% CI = 1.03 to 2.70) (Table 6).
DISCUSSION
Summary
In this nested case-control study of UK 
general practice data, after adjusting 
for covariates, women with exposure to 
DVA within the past 12 months were two 
times more likely to have had at least 
one consultation for EC, compared with 
women with no exposure to DVA. There was 
also some evidence that, after adjusting 
for covariates, women with exposure to 
DVA within the past 12 months were >1.5 
times more likely to have had multiple 
consultations for EC, compared with 
women without such exposure.
Strengths and limitations
The main strengths of this study are the 
coverage and quality of the CPRD data, and 
the representativeness of included cases. 
CPRD data are entered by clinicians during 
routine consultations in general practice, 
rather than for research purposes. As 
practice-based prescribing is generally 
electronic, prescriptions for EC will 
automatically be captured by GP software 
systems, leading to good ascertainment 
of cases. In addition, data quality for 
patients and practices are monitored by 
CPRD internal processes for validity and 
completeness, and active patients (as 
are included in this study) are generally 
representative of the UK population in 
terms of age and sex.27
This study’s main limitation is the 
under-recording of DVA in electronic 
medical records, which could attenuate 
the association between exposure to 
DVA and consultations for EC. The first 
UK study on DVA in primary care found 
an 83% under-recording of DVA exposure 
when comparing rates in electronic 
medical records with patient’s self-
reported rates.33 Another study found that, 
although multiple Read codes exist for 
DVA, recording practices vary considerably 
across UK general practice.34 Additionally, 
there is a potential misclassification of 
controls, due to the increasing availability 
of EC from varied providers during the 
past 10 years.35 Though the authors’ cases 
sought EC through general practice, the 
controls could either have not used EC 
(true controls) or obtained it elsewhere 
(misclassified controls). The authors also 
did not adjust their models for misuse of 
substances other than alcohol, known to 
be associated with DVA.36 Their findings 
are also restricted to consultations for EC 
provided by clinicians in general practice. 
Data from other sources of EC provision, 
such as sexual and reproductive health 
services and community pharmacies, could 
not be linked to CPRD due to regulatory, 
technical, and logistical reasons. The 
authors estimate that they have captured 
around 30% of the total provision of EC.37 
Considering these limitations, the authors 
anticipate that the true association between 
DVA and EC is higher than the results they 
have presented here.
Comparison with existing literature
This study supports the recent systematic 
review of cross-sectional studies that found 
some evidence for an association between 
exposure to DVA and increased use of EC.5 
The two main reasons for seeking EC are 
women’s fear that the contraceptive method 
they used would not work, and women’s fear 
of unintended pregnancy after unprotected 
intercourse.38 A recent meta-analysis 
suggested a causal relationship between 
exposure to DVA and reduction in women’s 
use of regular contraception.4 The authors 
can further speculate that, due to the 
reduction in use of regular contraception, 
women exposed to DVA are more likely to 
have unprotected intercourse and therefore 
might need more EC compared with women 
unexposed to DVA. Another mechanism 
connecting DVA and unprotected intercourse 
is reproductive coercion — a pattern of male 
behaviour aimed at controlling women’s 
Table 6. Association of domestic violence and abuse with having 
multiple consultations for emergency contraception, multivariable 
logistic regressions models 
Model  Adjusted OR (95% CI) P-value
Previous 12 months DVAa  1.68 (1.12 to 2.50) 0.011
Previous 12 months DVAa and age categories  1.65 (1.11 to 2.46) 0.014
Previous 12 months DVAa and number of pregnancies  1.57 (1.05 to 2.34) 0.028
Previous 12 months DVAa and number of children  1.66 (1.11 to 2.48) 0.013
Previous 12 months DVAa and record of alcohol abuseb  1.67 (1.12 to 2.50) 0.012
Previous 12 months DVAa and record of   1.65 (1.11 to 2.47) 0.014 
depression/depressive episodec
Full model  1.48 (0.99 to 2.21) 0.058
Full model and previous 12 months DVAa  15–24 0.96 (0.43 to 2.17) 0.923 
multiplied by age interaction 25–39 1.67 (1.03 to 2.70) 0.038 
 40–49 3.44 (0.67 to 17.81) 0.140
aBefore index date. bSince age 15, before index date. cWithin 2 years before index date. DVA = domestic violence 
and abuse. OR = odds ratio.
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reproductive outcomes through birth control 
sabotage or pregnancy coercion.39,40
The authors’ findings are in line with the US 
study on the effect of DVA on contraceptive 
patterns, though their effect estimates are 
much smaller.41 Fantasia et al analysed 
medical records from four family planning 
clinics and found that exposure to DVA in 
the previous 12 months was associated 
with a 6.5-fold increase in use of EC 
(95% CI = 3.8 to 9.3).41 Several factors could 
contribute to the difference in the effect size: 
study settings, national differences in the 
provision of EC, and methods of identifying 
and recording exposure, outcome, and 
confounding variables.
The authors found some evidence that 
women exposed to DVA can seek EC from 
GPs on multiple occasions. This suggests 
women exposed to DVA may use EC instead 
of regular contraceptive methods, which 
they cannot access because of reproductive 
coercion, coercive control, or economic 
abuse. This is in line with the US survey in 
five family planning clinics which showed 
that women who had experienced DVA 
and reproductive coercion were two times 
more likely to report multiple use of EC 
in the previous 3 months (OR 2.40, 95% 
CI = 1.41 to 4.09).42 Reproductive coercion 
was not captured in the present study, 
which could have resulted in the smaller 
effect estimate. However, the authors 
considered the temporality of the exposure 
versus outcome, which was not possible in 
the US study.42
Implications for research and practice 
Future studies should use data linkage 
from core providers of EC (general practice, 
sexual and reproductive health services, 
and pharmacies) to analyse the total 
provision of EC. 
DVA interventions for primary care (for 
example, IRIS in the UK) should be updated 
to include new evidence on the association 
between exposure to DVA and increased use 
of EC. All providers of EC should be aware 
that a request for EC can indicate possible 
exposure to DVA. A consultation for EC in 
general practice is an appropriate context 
for asking about DVA and responding to 
disclosure in line with the WHO LIVES14 
principles.
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